Medicus Pharma Ltd. MDCX.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 94.13% | 120.44% | 134.16% | 66.51% | 58.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 102.64% | 99.40% | 129.34% | 91.91% | 88.27% |
| Operating Income | -102.64% | -99.40% | -129.34% | -91.91% | -88.27% |
| Income Before Tax | -231.87% | -252.02% | -323.84% | -297.34% | -76.54% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -231.87% | -252.02% | -323.84% | -297.34% | -76.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -231.48% | -252.02% | -323.84% | -297.34% | -76.54% |
| EBIT | -102.64% | -99.40% | -129.34% | -91.91% | -88.27% |
| EBITDA | -- | -- | -- | 53.12% | -11.03% |
| EPS Basic | -75.07% | -89.21% | -130.60% | -114.41% | 38.96% |
| Normalized Basic EPS | -40.05% | -52.17% | -87.61% | -71.68% | 38.68% |
| EPS Diluted | -75.07% | -89.21% | -130.60% | -114.41% | 38.96% |
| Normalized Diluted EPS | -40.05% | -52.17% | -87.61% | -71.68% | 38.68% |
| Average Basic Shares Outstanding | 156.99% | 96.31% | 71.73% | 66.80% | 79.63% |
| Average Diluted Shares Outstanding | 156.99% | 96.31% | 71.73% | 66.80% | 79.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |